DEA schedule
Is naproxen a controlled substance?
Federal schedule for naproxen from the FDA NDC directory, checked against the DEA controlled substances list.
Source: FDA NDC Directory file dated 2026-10-22. Publisher page
No. Naproxen is not a federally controlled substance. None of its FDA NDC listings carries a DEA schedule, and naproxen is not on the DEA controlled substances list.
Run it in Rivvi
Which 2027 plans near you dropped or restricted naproxen?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.
Schedule check
| Source | What it lists |
|---|---|
| FDA NDC directory | 224 prescription listings from 61 labelers, none with a DEA schedule |
| DEA controlled substances list | naproxen is not on the list |
Naproxen NDC listings
| NDC | Product | Form | Strength | Labeler | DEA schedule |
|---|---|---|---|---|---|
| 24979-249 | Naprelan | tablet, film coated, extended release | 375 mg/1 | Upsher-Smith Laboratories, LLC | None |
| 52427-272 | Naprelan | tablet, film coated, extended release | 375 mg/1 | Almatica Pharma LLC | None |
| 24979-250 | Naprelan | tablet, film coated, extended release | 500 mg/1 | Upsher-Smith Laboratories, LLC | None |
| 52427-273 | Naprelan | tablet, film coated, extended release | 500 mg/1 | Almatica Pharma LLC | None |
| 24979-251 | Naprelan | tablet, film coated, extended release | 750 mg/1 | Upsher-Smith Laboratories, LLC | None |
| 0054-3630 | Naproxen | suspension | 125 mg/5mL | Hikma Pharmaceuticals USA Inc. | None |
| 42192-619 | Naproxen | suspension | 125 mg/5mL | Acella Pharmaceuticals, LLC | None |
| 59651-528 | Naproxen | suspension | 125 mg/5mL | Aurobindo Pharma Limited | None |
| 31722-682 | Naproxen | suspension | 25 mg/mL | Camber Pharmaceuticals, Inc. | None |
| 69238-1730 | Naproxen | suspension | 25 mg/mL | Amneal Pharmaceuticals NY LLC | None |
| 25000-138 | Naproxen | tablet | 250 mg/1 | MARKSANS PHARMA LIMITED | None |
| 43063-600 | Naproxen | tablet | 250 mg/1 | PD-Rx Pharmaceuticals, Inc. | None |
| 43353-216 | Naproxen | tablet | 250 mg/1 | Aphena Pharma Solutions - Tennessee, LLC | None |
| 49483-619 | NAPROXEN | tablet | 250 mg/1 | TIME CAP LABORATORIES | None |
| 50090-2788 | Naproxen | tablet | 250 mg/1 | A-S Medication Solutions | None |
| 50090-4752 | Naproxen | tablet | 250 mg/1 | A-S Medication Solutions | None |
| 50228-434 | Naproxen | tablet | 250 mg/1 | ScieGen Pharmaceuticals, Inc. | None |
| 50268-594 | Naproxen | tablet | 250 mg/1 | AvPAK | None |
| 53746-188 | Naproxen | tablet | 250 mg/1 | Amneal Pharmaceuticals of New York LLC | None |
| 62207-745 | Naproxen | tablet | 250 mg/1 | Granules India Ltd | None |
| 63187-461 | Naproxen | tablet | 250 mg/1 | Proficient Rx LP | None |
| 63629-8511 | Naproxen | tablet | 250 mg/1 | Bryant Ranch Prepack | None |
| 65162-188 | Naproxen | tablet | 250 mg/1 | Amneal Pharmaceuticals LLC | None |
| 65862-520 | Naproxen | tablet | 250 mg/1 | Aurobindo Pharma Limited | None |
| 67046-0499 | Naproxen | tablet | 250 mg/1 | Coupler LLC | None |
| 68071-4510 | NAPROXEN | tablet | 250 mg/1 | NuCare Pharmaceuticals,Inc. | None |
| 68462-188 | Naproxen | tablet | 250 mg/1 | Glenmark Pharmaceuticals Inc., USA | None |
| 69097-853 | naproxen | tablet | 250 mg/1 | Cipla USA Inc. | None |
| 70010-137 | Naproxen | tablet | 250 mg/1 | Granules Pharmaceuticals Inc. | None |
| 70518-4514 | Naproxen | tablet | 250 mg/1 | REMEDYREPACK INC. | None |
| 71335-0217 | Naproxen | tablet | 250 mg/1 | Bryant Ranch Prepack | None |
| 71335-0973 | NAPROXEN | tablet | 250 mg/1 | Bryant Ranch Prepack | None |
| 71335-1869 | Naproxen | tablet | 250 mg/1 | Bryant Ranch Prepack | None |
| 71610-592 | Naproxen | tablet | 250 mg/1 | Aphena Pharma Solutions - Tennessee, LLC | None |
| 76282-340 | Naproxen | tablet | 250 mg/1 | Exelan Pharmaceuticals, Inc. | None |
| 76420-787 | Naproxen | tablet | 250 mg/1 | Asclemed USA, Inc. | None |
| 77771-434 | Naproxen | tablet | 250 mg/1 | Radha Pharmaceuticals, Inc. | None |
| 82804-229 | Naproxen | tablet | 250 mg/1 | Proficient Rx LP | None |
| 85534-0058 | Naproxen | tablet | 250 mg/1 | HAWAII REPACK, INC. | None |
| 85766-105 | Naproxen | tablet | 250 mg/1 | Sportpharm LLC | None |
Showing 40 of 224 listings.
Questions
Is naproxen a controlled substance?
No. Naproxen is not a federally controlled substance. None of its FDA NDC listings carries a DEA schedule, and naproxen is not on the DEA controlled substances list.
Is naproxen a narcotic?
No. Naproxen is not on the DEA controlled substances list, so the DEA does not classify it as a narcotic. Its FDA established pharmacologic class is Nonsteroidal Anti-inflammatory Drug.
Does this page cover state schedules?
No. This page reports the federal schedule only. Some states schedule drugs on their own; check your state board of pharmacy.
More on Naproxen
- What is Naproxen used for?FDA label uses
- Generic for NaprosynFDA Orange Book
- Generic for Ec-naprosynFDA Orange Book
- Generic for NaprelanFDA Orange Book
- Generic for AnaproxFDA Orange Book
- Generic for Anaprox DSFDA Orange Book
- Nonsteroidal Anti-inflammatory Drugs listFDA drug class
- NDC 24979-249Naproxen NDC record
- NDC 24979-250Naproxen NDC record
- NDC 24979-251Naproxen NDC record